Lun-Xu Liu (Lunxu Liu)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 44

Top Topics

Binding Protein

Small Cell Lung Cancer

Top Venues

Annals of surgical oncology

Thoracic cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jian Zhang, Kejia Zhao, Wenjing Zhou, Ran Kang, Shiyou Wei, Yueli Shu, Cheng Yu, Yin Ku, Yonghong Mao, Hao Luo, Juqin Yang, Jiandong Mei, Qiang Pu, Senyi Deng, Zhengyu Zha, Gang Yuan, Shensi Shen, Yaohui Chen, Lun-Xu Liu
Tet methylcytosine dioxygenase 2 (TET2) deficiency elicits EGFR-TKI (tyrosine kinase inhibitors) resistance in non-small cell lung cancer. Signal transduction and targeted therapy 9 (1) (2024)
Fuqiang Dai, Cong Chen, Guanyu Zhou, Xintian Wang, Longyong Mei, Nanzhi Luo, Wenjing Zhou, Tao Li, Deng Bo, Lun-Xu Liu, Yun Wang
Subsequent surgical treatment or maintenance immunotherapy in stage III lung cancer patients achieving a favorable response following neoadjuvant immunotherapy: A matched retrospective cohort study from the surgical perspective. Thoracic cancer (2024)
Fuqiang Dai, Cong Chen, Guanyu Zhou, Xintian Wang, Longyong Mei, Nanzhi Luo, Wenjing Zhou, Tao Li, Deng Bo, Lun-Xu Liu, Yun Wang
Subsequent surgical treatment or maintenance immunotherapy in stage III lung cancer patients achieving a favorable response following neoadjuvant immunotherapy: A matched retrospective cohort study from the surgical perspective. Thoracic cancer 15 (10) (2024)
Fuqiang Dai, Cong Chen, Guanyu Zhou, Xintian Wang, Longyong Mei, Nanzhi Luo, Wenjing Zhou, Tao Li, Deng Bo, Lun-Xu Liu, Yun Wang
Subsequent surgical treatment or maintenance immunotherapy in stage III lung cancer patients achieving a favorable response following neoadjuvant immunotherapy: A matched retrospective cohort study from the surgical perspective. Thoracic cancer 15 (10) (2024)
Dongsheng Wu, Zhipeng Gong, Xiaohu Hao, Lun-Xu Liu
Genetic perturbation of IL-6 receptor signaling pathway and risk of multiple respiratory diseases. Journal of translational medicine 22 (1) (2024)
Bo Dong, Mengyao Wang, Kaixiu Li, Zuwei Li, Lun-Xu Liu, Shensi Shen
Plasma proteometabolome in lung cancer: exploring biomarkers through bidirectional Mendelian randomization and colocalization analysis. Human molecular genetics (2024)
Dongsheng Wu, Zhipeng Gong, Xiaohu Hao, Lun-Xu Liu
Genetic perturbation of IL-6 receptor signaling pathway and risk of multiple respiratory diseases. Journal of translational medicine 22 (1) (2024)
Jian Zhang, Kejia Zhao, Wenjing Zhou, Ran Kang, Shiyou Wei, Yueli Shu, Cheng Yu, Yin Ku, Yonghong Mao, Hao Luo, Juqin Yang, Jiandong Mei, Qiang Pu, Senyi Deng, Zhengyu Zha, Gang Yuan, Shensi Shen, Yaohui Chen, Lun-Xu Liu
Tet methylcytosine dioxygenase 2 (TET2) deficiency elicits EGFR-TKI (tyrosine kinase inhibitors) resistance in non-small cell lung cancer. Signal transduction and targeted therapy 9 (1) (2024)
Dongsheng Wu, Zhipeng Gong, Xiaohu Hao, Lun-Xu Liu
Genetic perturbation of IL-6 receptor signaling pathway and risk of multiple respiratory diseases. Journal of translational medicine 22 (1) (2024)
Fuqiang Dai, Cong Chen, Guanyu Zhou, Xintian Wang, Longyong Mei, Nanzhi Luo, Wenjing Zhou, Tao Li, Deng Bo, Lun-Xu Liu, Yun Wang
Subsequent surgical treatment or maintenance immunotherapy in stage III lung cancer patients achieving a favorable response following neoadjuvant immunotherapy: A matched retrospective cohort study from the surgical perspective. Thoracic cancer 15 (10) (2024)
Jian Zhang, Kejia Zhao, Wenjing Zhou, Ran Kang, Shiyou Wei, Yueli Shu, Cheng Yu, Yin Ku, Yonghong Mao, Hao Luo, Juqin Yang, Jiandong Mei, Qiang Pu, Senyi Deng, Zhengyu Zha, Gang Yuan, Shensi Shen, Yaohui Chen, Lun-Xu Liu
Tet methylcytosine dioxygenase 2 (TET2) deficiency elicits EGFR-TKI (tyrosine kinase inhibitors) resistance in non-small cell lung cancer. Signal transduction and targeted therapy 9 (1) (2024)
Fuqiang Dai, Cong Chen, Guanyu Zhou, Xintian Wang, Longyong Mei, Nanzhi Luo, Wenjing Zhou, Tao Li, Deng Bo, Lun-Xu Liu, Yun Wang
Subsequent surgical treatment or maintenance immunotherapy in stage III lung cancer patients achieving a favorable response following neoadjuvant immunotherapy: A matched retrospective cohort study from the surgical perspective. Thoracic cancer 15 (10) (2024)
Dongsheng Wu, Zhipeng Gong, Xiaohu Hao, Lun-Xu Liu
Genetic perturbation of IL-6 receptor signaling pathway and risk of multiple respiratory diseases. Journal of translational medicine 22 (1) (2024)
Jian Zhang, Kejia Zhao, Wenjing Zhou, Ran Kang, Shiyou Wei, Yueli Shu, Cheng Yu, Yin Ku, Yonghong Mao, Hao Luo, Juqin Yang, Jiandong Mei, Qiang Pu, Senyi Deng, Zhengyu Zha, Gang Yuan, Shensi Shen, Yaohui Chen, Lun-Xu Liu
Tet methylcytosine dioxygenase 2 (TET2) deficiency elicits EGFR-TKI (tyrosine kinase inhibitors) resistance in non-small cell lung cancer. Signal transduction and targeted therapy 9 (1) (2024)
Kejia Zhao, Jiandong Mei, Binbin Hu, Chenglin Guo, Shiyou Wei, Xudong Yang, Zhenyu Yang, Jian Zhang, Yin Ku, Yao Zheng, Di Wu, Shasha Li, Yonghong Mao, Yu Ding, Lun-Xu Liu
Complete dissection of right paratracheal lymph nodes (stations 2R and 4R) is critical to improve the prognosis of lung cancer patients: A retrospective cohort study. Thoracic cancer (2023)
Yi Liu, Hongjin Lai, Ren Zhang, Liang Xia, Lun-Xu Liu
Causal relationship between gastro-esophageal reflux disease and risk of lung cancer: insights from multivariable Mendelian randomization and mediation analysis. International journal of epidemiology (2023)
Tengyong Wang, Jian Zhou, Quan Zheng, Dongsheng Wu, Tianyi Lu, Mingying Lin, Qiang Pu, Jiandong Mei, Lun-Xu Liu
A Competing Risk Model Nomogram to Predict the Long-Term Prognosis of Lung Carcinoid. Annals of surgical oncology (2023)
Liang Xia, Ying Yang, Weizhi Chen, Lun-Xu Liu
Perioperative ctDNA-Based MRD Detection in NSCLC-Response. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
Ying Zhu, Qiang Pu, Qiongyin Zhang, Yang Liu, Yongfang Ma, Yue Yuan, Lun-Xu Liu, Wen Zhu
Selenium-binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non-small cell lung cancer. Cancer medicine (2023)
Dongsheng Wu, Jian Zhou, Yuchen Huang, Quan Zheng, Tengyong Wang, Lun-Xu Liu
Genetically predicted childhood body mass index and lung cancer susceptibility: A two-sample Mendelian randomization study. Cancer medicine (2023)
Tengyong Wang, Jian Zhou, Quan Zheng, Dongsheng Wu, Tianyi Lu, Mingying Lin, Qiang Pu, Jiandong Mei, Lun-Xu Liu
ASO Visual Abstract: A Competing Risk Model Nomogram to Predict the Long-Term Prognosis of Lung Carcinoid. Annals of surgical oncology (2023)
Tengyong Wang, Jian Zhou, Lun-Xu Liu
ASO Author Reflections: Prediction of Long-Term Cancer-Specific Survival of Lung Carcinoid Patients. Annals of surgical oncology (2023)
Liang Xia, Weizhi Chen, Lun-Xu Liu
Perioperative ctDNA-Based MRD Detection in NSCLC-Response. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (15) (2022)
Ying Zhu, Qiang Pu, Qiongyin Zhang, Yang Liu, Yongfang Ma, Yue Yuan, Lun-Xu Liu, Wen Zhu
Selenium-binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non-small-cell lung cancer. Cancer medicine (2022)
Zhenyu Yang, Zihuai Wang, Lun-Xu Liu
ASO Author Reflections: Comprehensive Comparison of N Staging Subclassification Methods for Non-Small-Cell Lung Cancer. Annals of surgical oncology 29 (13) (2022)
Lei Chen, Zhenyu Yang, Ruichen Cui, Lun-Xu Liu
Feasibility and safety of secondary video-assisted thoracoscopic surgery for ipsilateral lung cancer after prior pulmonary resection. Thoracic cancer (2022)
Shiyou Wei, Delong Yin, Shengnan Yu, Xiang Lin, Milan R Savani, Kuang Du, Yin Ku, Di Wu, Shasha Li, Hao Liu, Meng Tian, Yaohui Chen, Michelle Bowie, Seethalakshmi Hariharan, Matthew S Waitkus, Stephen T Keir, Eric T Sugarman, Rebecca A Deek, Marilyne Labrie, Mustafa Khasraw, Yiling Lu, Gordon B Mills, Meenhard Herlyn, Kongming Wu, Lun-Xu Liu, Zhi Wei, Keith T Flaherty, Kalil G Abdullah, Gao Zhang, David M Ashley
Antitumor Activity of a Mitochondrial-Targeted HSP90 Inhibitor in Gliomas. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (10) (2022)
Tengyong Wang, Jian Zhou, Yaxin Wang, Quan Zheng, Zhangyu Lin, Guangchen Li, Jiandong Mei, Lun-Xu Liu
Clinicopathological characteristics and prognosis of resectable lung adenosquamous carcinoma: a population-based study of the SEER database. Japanese journal of clinical oncology 52 (10) (2022)
Zihuai Wang, Zhenyu Yang, Sijia Li, Junqi Zhang, Liang Xia, Jian Zhou, Nan Chen, Chenglin Guo, Lun-Xu Liu
ASO Visual Abstract: A Comprehensive Comparison of Different Nodal Subclassification Methods in Surgical Resected Non-Small Cell Lung Cancer Patients. Annals of surgical oncology 29 (13) (2022)
Jian Zhang, Houde Li, Yu Liu, Kejia Zhao, Shiyou Wei, Eric T Sugarman, Lun-Xu Liu, Gao Zhang
Targeting HSP90 as a Novel Therapy for Cancer: Mechanistic Insights and Translational Relevance. Cells 11 (18) (2022)
Zihuai Wang, Zhenyu Yang, Sijia Li, Junqi Zhang, Liang Xia, Jian Zhou, Nan Chen, Chenglin Guo, Lun-Xu Liu
A Comprehensive Comparison of Different Nodal Subclassification Methods in Surgically Resected Non-Small-Cell Lung Cancer Patients. Annals of surgical oncology 29 (13) (2022)
Si-Yang Liu, Hua Bao, Qun Wang, Wei-Min Mao, Yuchen Han, Xiaoling Tong, Song-Tao Xu, Lin Wu, Yu-Cheng Wei, Yong-Yu Liu, Chun Chen, Ying Cheng, Rong Yin, Fan Yang, Sheng-Xiang Ren, Xiao-Fei Li, Jian Li, Cheng Huang, Zhi-Dong Liu, Shun Xu, Ke-Neng Chen, Shi-Dong Xu, Lun-Xu Liu, Ping Yu, Bu-Hai Wang, Hai-Tao Ma, Hong-Hong Yan, Song Dong, Xu Chao Zhang, Jian Su, Jin-Ji Yang, Xue-Ning Yang, Qing Zhou, Xue Wu, Yang W Shao, Wen-Zhao Zhong, Yi-Long Wu
Genomic signatures define three subtypes of EGFR-mutant stage II-III non-small-cell lung cancer with distinct adjuvant therapy outcomes. Nature communications 12 (1) (2021)
Fanyi Gan, Liang Xia, Yushang Yang, Qiang Pu, Lun-Xu Liu
Fatal congenital lobar emphysema in a puerpera: a case report and literature review. BMC pulmonary medicine 21 (1) (2021)
Kuang Du, Shiyou Wei, Zhi Wei, Dennie T Frederick, Benchun Miao, Tabea Moll, Tian Tian, Eric Sugarman, Dmitry I Gabrilovich, Ryan J Sullivan, Lun-Xu Liu, Keith T Flaherty, Genevieve Marie Boland, Meenhard Herylyn, Gao Zhang
Pathway signatures derived from on-treatment tumor specimens predict response to anti-PD1 blockade in metastatic melanoma. Nature communications 12 (1) (2021)
Michaël Cerezo, Caroline Robert, Lun-Xu Liu, Shensi Shen
The Role of mRNA Translational Control in Tumor Immune Escape and Immunotherapy Resistance. Cancer research 81 (22) (2021)
Liang Xia, Jiandong Mei, Ran Kang, Senyi Deng, Yaohui Chen, Ying Yang, Gang Feng, Yulan Deng, Fanyi Gan, Yidan Lin, Qiang Pu, Lin Ma, Feng Lin, Yong Yuan, Yang Hu, Chenglin Guo, Hu Liao, Chengwu Liu, Yunke Zhu, Wenping Wang, Zheng Liu, Yuyang Xu, Kaidi Li, Chuan Li, Qingyun Li, Ji He, Weizhi Chen, Xiaolong Zhang, Yingli Kou, Yun Wang, Zhu Wu, Guowei Che, Longqi Chen, Lun-Xu Liu
Perioperative ctDNA-based Molecular Residual Disease Detection for Non-Small Cell Lung Cancer: A Prospective Multicenter Cohort Study (LUNGCA-1). Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Shengnan Yu, Shiyou Wei, Milan R Savani, Xiang Lin, Kuang Du, Ilgen Mender, Silvia Siteni, Themistoklis Vasilopoulos, Zachary J Reitman, Yin Ku, Di Wu, Hao Liu, Meng Tian, Yaohui Chen, Marilyne Labrie, Casey M Charbonneau, Eric Sugarman, Michelle Bowie, Seethalakshmi Hariharan, Matthew S Waitkus, Wen Jiang, Roger E McLendon, Edward Pan, Mustafa Khasraw, Kyle M Walsh, Yiling Lu, Meenhard Herlyn, Gordon B Mills, Utz Herbig, Zhi Wei, Stephen T Keir, Keith Flaherty, Lun-Xu Liu, Kongming Wu, Jerry W Shay, Kalil G Abdullah, Gao Zhang, David M Ashley
A Modified Nucleoside 6-Thio-2'-Deoxyguanosine Exhibits Antitumor Activity in Gliomas. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Chengwu Liu, Wenping Wang, Jiandong Mei, Yunke Zhu, Qiang Pu, Lun-Xu Liu
Uniportal Thoracoscopic Single-Direction Basal Subsegmentectomy (Left S10a+ci): Trans-Inferior-Pulmonary-Ligament Approach. Annals of surgical oncology (2021)
Yunke Zhu, Liang Xia, Chengwu Liu, Feng Lin, Lun-Xu Liu
Uniportal Single-Direction Thoracoscopic Right S9 Segmentectomy: Trans-Inferior-Pulmonary-Ligament Approach. Annals of surgical oncology 28 (11) (2021)
Jian Zhou, Hu Liao, Zhangyu Lin, Mengyuan Lyu, Weelic Chong, Nan Chen, Yang Hai, Zihuai Wang, Tianjian Lu, Lun-Xu Liu
A new basic thoracoscopic surgical skill training and assessment system using automatic scoring techniques. Surgical endoscopy (2021)
Chengwu Liu, Shiyou Wei, Lun-Xu Liu
ASO Author Reflections: Individualized Mediastinal Lymph Node Dissection for Lung Cancer: Do Not Neglect Station 3A Lymph Node. Annals of surgical oncology 27 (Suppl 3) (2020)
Chengwu Liu, Shiyou Wei, Chenglin Guo, Jiandong Mei, Qiang Pu, Lun-Xu Liu
Clinical Significance of Station 3A Lymph Node Dissection in Patients with Right-Side Non-Small-Cell Lung Cancer: A Retrospective Propensity-Matched Analysis. Annals of surgical oncology 28 (1) (2020)
Yanbo Yang, Jiandong Mei, Feng Lin, Qiang Pu, Lin Ma, Chengwu Liu, Yunke Zhu, Chenglin Guo, Liang Xia, Lun-Xu Liu
Comparison of the Short- and Long-term Outcomes of Video-assisted Thoracoscopic Surgery versus Open Thoracotomy Bronchial Sleeve Lobectomy for Central Lung Cancer: A Retrospective Propensity Score Matched Cohort Study. Annals of surgical oncology 27 (11) (2020)
Wen-Zhao Zhong, Qun Wang, Wei-Min Mao, Song-Tao Xu, Lin Wu, Yu-Cheng Wei, Yong-Yu Liu, Chun Chen, Ying Cheng, Rong Yin, Fan Yang, Sheng-Xiang Ren, Xiao-Fei Li, Jian Li, Cheng Huang, Zhi-Dong Liu, Shun Xu, Ke-Neng Chen, Shi-Dong Xu, Lun-Xu Liu, Ping Yu, Bu-Hai Wang, Hai-Tao Ma, Jin-Ji Yang, Hong-Hong Yan, Xue-Ning Yang, Si-Yang Liu, Qing Zhou, Yi-Long Wu
Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (7) (2020)